Analystreport

Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

Opiant Pharmaceuticals, Inc.  (OPNT) 
Last opiant pharmaceuticals, inc. earnings: 3/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.opiant.com/investor-overview